Unaudited Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Cash flows from operating activities:
Net income (loss)	$ 999	$ (22,340)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation and amortization	2,991	2,341
Stock-based compensation expense	1,756	1,375
Inventory impairments and abandonments	1,356	0
Deferred and other income tax expense (benefit)	318	(765)
Gain (Loss) on Disposition of Assets	(771)	0
Change in allowance for doubtful accounts	(131)	22
Equity in income of unconsolidated entities and marketable securities	(60)	(142)
Cash distributions of income from marketable securities and unconsolidated entities	0	34
Changes in operating assets and liabilities:
Decrease in accounts receivable	1,955	2,091
Decrease in income tax receivable	150	0
Increase in inventory	(28,168)	(104,434)
Decrease in other assets	1,660	1,159
Decrease in trade accounts payable	(32,144)	(40,392)
Decrease in other liabilities	(27,760)	(11,432)
Other changes	0	(49)
Net cash used in operating activities	(77,849)	(172,532)
Cash flows from investing activities:
Capital expenditures	(2,663)	(2,934)
Proceeds from Sale of Buildings	2,437	0
Investments in unconsolidated entities	(1,779)	(1,144)
Return of capital from unconsolidated entities	1,142	0
Increase in Restricted Cash	(1,119)	(1,445)
Decrease in Restricted Cash	669	294
Net cash used in investing activities	(1,313)	(5,229)
Cash flows from financing activities:
Repayment of debt	(26,926)	(7,388)
Debt issuance costs	(413)	(126)
Other financing activities	(201)	(199)
Net cash used in financing activities	(27,540)	(7,713)
Decrease in cash and cash equivalents	(106,702)	(185,474)
Cash and cash equivalents at beginning of period	251,583	324,154
Cash and cash equivalents at end of period	$ 144,881	$ 138,680